Trials / Completed
CompletedNCT01381770
Platelet-derived Factors for Treatment of Muscular Lesions
Platelet-derived Factors for Treatment of Muscular Lesions: a Phase II Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that platelet-derived repairing factors are effective and safe in the treatment of muscular lesion grade 2 or 3, a Phase II, open-label, single arm, single centre has been designed. Sample size will be 25.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | platelet-derived repairing factors | autologous platelet lysate injection within 24 hours from lesion |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-12-01
- Completion
- 2013-05-01
- First posted
- 2011-06-27
- Last updated
- 2015-08-25
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01381770. Inclusion in this directory is not an endorsement.